Skip to content
The Nexus
DossierENTITY

triple-negative breast cancer

Coverage of triple-negative breast cancer in the Nexus archive.

Earliest in view: May 13 · 00:00 UTCMost recent: Jun 18 · 14:05 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJun 18 · 14:05 UTCTIMES OF ISRAEL
    Israeli drug-free nanomedicine gives fresh hope in battling aggressive breast cancer

    Technion scientists developed a drug-free nanomedicine that halted 'triple-negative' breast cancer tumors in female mice models. The nanomedicine uses materials already approved as safe for humans by international regulatory bodies.

  • HEALTHJun 13 · 11:00 UTCCHICAGO SUN-TIMES
    For southwest suburban woman, a breast cancer diagnosis and the queer affirmation that kept her going

    Alix Shulman, a 49-year-old southwest suburban woman, was diagnosed with stage 3 IIB triple-negative breast cancer and underwent chemotherapy and a bilateral mastectomy. Her recovery was supported by queer-affirming healthcare providers and her wife, Lisa, highlighting the importance of inclusive care for LGBTQ+ cancer patients.

  • SCIENCEMay 25 · 03:03 UTCSCIENCE DAILY
    Scientists supercharge natural killer cells to fight aggressive cancers

    Scientists at McGill University have developed a method to enhance natural killer (NK) cells by blocking two proteins, making them more effective against aggressive cancers like leukemia, glioblastoma, kidney cancer, and triple-negative breast cancer.

  • HEALTHMay 13 · 00:00 UTCNATURE NEWS
    Ecotypes of triple-negative breast cancer in response to chemotherapy

    Researchers found that macrophage subtypes and cancer-cell metaprograms are associated with a good response to neoadjuvant chemotherapy in triple-negative breast cancer patients. The study highlights the importance of interferon signalling, HLA expression, and cell cycle activity in treatment outcomes. This discovery could lead to more effective personalized treatment strategies.